•  
  •  
  •  
  •  

2025-12-07 09:11:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • RailTel Corporation of India Ltd receives LOA for order worth Rs. 14.40 crores
  • Capital Trade Links Ltd enters into MOU with CER Rooftop Pvt Ltd
  • ARCL Organics Ltd signs MOU for land, asset purchase
  • Takyon Networks Ltd receives order from Hindustan Aeronautics Ltd, Kanpur
  • Excelsoft and AQA Announce Joint AI Taskforce to research Advanced Ethical and Secure AI for E-Marking of Handwritten Student Responses

Keywords Selected:  Injection

Stock Report

  • Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
  • Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
  • Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP
  • Lupin Launches Liraglutide Injection in the United States
  • Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime for Treatment of Serious GramNegative Infections
  • Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
  • Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
  • Lupin Launches Glucagon for Injection USP, 1mg/Vial in the United States
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Gland Pharma Receives Approval for Angiotensin II Acetate Injection
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • Gland Pharma receives approval for Acetaminophen Injection
  • Amneal Pharmaceuticals launches 2nd NDA Bortezomib for injection3.5mg/1.4ml in US
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial - Single-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
  • Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Pricol Ltd announces Strategic Acquisition of Sundaram Auto Components Ltd's Injection Moulding Business
  • Wockhardt files fast-acting Insulin Aspart injection with DCGI
  • Windsor Machines Ltd launches India's largest two-platen injection moulding machine

Latest Post

  • RailTel Corporation of India Ltd receives LOA for order worth Rs. 14.40 crores
  • Capital Trade Links Ltd enters into MOU with CER Rooftop Pvt Ltd
  • ARCL Organics Ltd signs MOU for land, asset purchase
  • Takyon Networks Ltd receives order from Hindustan Aeronautics Ltd, Kanpur
  • Excelsoft and AQA Announce Joint AI Taskforce to research Advanced Ethical and Secure AI for E-Marking of Handwritten Student Responses


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024